Top 2 Health Care Stocks That May Crash In February

As of Feb. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.

Here's the latest list of major overbought players in this sector.

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

Orthofix Medical Inc. OFIX

Orthofix Medical announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, Feb. 25, 2025 before the opening bell. The company has a 52-week high of $20.73.
RSI Value: 77.9
OFIX Price Action: Shares of Orthofix Medical gained 3.1% to close at $18.76 on Tuesday.

Globus Medical Inc GMED

On Feb. 3, Interactive Brokers reported a year-over-year increase in daily average revenue trades for January. The company's stock gained around 10% over the past month and has a 52-week high of $94.93.
RSI Value: 74
GMED Price Action: Shares of Globus Medical fell 0.4% to close at $92.18 on Tuesday.

Read This Next: